Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8154 USD | +0.54% | +6.17% | +0.67% |
May. 09 | HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 25 | Transcript : HOOKIPA Pharma Inc. - Special Call |
Financials (USD)
Sales 2024 * | 55.47M | Sales 2025 * | 11.82M | Capitalization | 80.68M |
---|---|---|---|---|---|
Net income 2024 * | -46M | Net income 2025 * | -102M | EV / Sales 2024 * | 1.45 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.82 x |
P/E ratio 2024 * |
-2.63
x | P/E ratio 2025 * |
-1.29
x | Employees | 165 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.47% |
Latest transcript on HOOKIPA Pharma Inc.
1 day | +0.54% | ||
1 week | +6.17% | ||
Current month | -8.10% | ||
1 month | +6.60% | ||
3 months | +23.36% | ||
6 months | +57.11% | ||
Current year | +0.67% |
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.8154 | +0.54% | 282,217 |
24-05-16 | 0.811 | -5.59% | 663,506 |
24-05-15 | 0.859 | +4.15% | 383,790 |
24-05-14 | 0.8248 | +7.63% | 470,609 |
24-05-13 | 0.7663 | -0.22% | 346,655 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.67% | 80.68M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- HOOK Stock